Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05180630 · ClinicalTrials.gov registry record · NA
Sound Quality Comparisons With Different Hearing Aid Couplings and Venting Systems
A NA study of Hearing Loss, Sensorineural, sponsored by Sonova.
- Completed
- Registry status
- NA
- Development phase
- 17
- Enrollment target
- 1
- Study location
NCT05180630: Completed NA study of Hearing Loss, Sensorineural, sponsored by Sonova.
NCT05180630 is a NA study of Hearing Loss, Sensorineural that has completed, run by Sonova. The registered enrollment target is 17 participants, below the 785-participant average among 20 other Hearing Loss, Sensorineural trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05180630, a NA study of Hearing Loss, Sensorineural, has completed, sponsored by Sonova.
- COMPLETED
- Registry status
- NA
- Development phase
- 17 participants
- Enrollment target
- 1
- Study location
Study Summary
Participants will be comparing the sound quality of their own voice and the sound quality of streamed music using universal couplings and a custom earmold with a dynamic vent.
Primary Outcome
subjective rating on scale from 0 (worst) to 100 (best) for sound quality of streamed signal
Conditions Studied
Interventions
- DEVICE Audeo P90 hearing aid with custom earmolds using dynamic venting
- DEVICE Audeo P90 hearing aid with Open domes
- DEVICE Audeo P90 hearing aid with Vented domes
Study Locations (1)
Illinois
- Sonova US - Aurora
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 17 participants |
| Start Date | 2021-10-01 |
| Est. Completion | 2022-04-22 |
| Phase | NA |
What the finished NCT05180630 record still lists
NCT05180630 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 17 participants, a relatively small participant target, below the 785-participant average among 20 other Hearing Loss, Sensorineural trials with a reported enrollment target (98% lower).
The record links to 1 condition, with Hearing Loss, Sensorineural appearing as the primary indexed condition, and to 3 interventions - of which Audeo P90 hearing aid with custom earmolds using dynamic venting is the first listed.
NCT05180630 reports a single indexed study location in Illinois.
Frequently Asked Questions
What is clinical trial NCT05180630 about?
NCT05180630 is a clinical study titled "Sound Quality Comparisons With Different Hearing Aid Couplings and Venting Systems". Participants will be comparing the sound quality of their own voice and the sound quality of streamed music using universal couplings and a custom earmold with a dynamic vent.
What is the current status of trial NCT05180630?
This trial is currently completed. It is a NA study. The enrollment target is 17 participants. The study started on 2021-10-01. Estimated completion is 2022-04-22.
What conditions does trial NCT05180630 study?
This clinical trial studies the following conditions: Hearing Loss, Sensorineural.
What interventions are being tested in trial NCT05180630?
The interventions under investigation include: Audeo P90 hearing aid with custom earmolds using dynamic venting (DEVICE), Audeo P90 hearing aid with Open domes (DEVICE), Audeo P90 hearing aid with Vented domes (DEVICE).
Who is sponsoring clinical trial NCT05180630?
This trial is sponsored by Sonova, which has 29 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05180630 being conducted?
This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Hearing Loss, Sensorineural
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05180630's enrollment target sits among peer trials
17 20th of 20 higher than 1 of 20 other Hearing Loss, Sensorineural trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Hearing Loss, Sensorineural trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Clinical Utility of Residual Hearing in the Cochlear Implant Ear
RECRUITING · NA
-
Barriers and Facilitators to OTC Hearing Aids Success
RECRUITING · NA
-
Preschool Hearing Screening
RECRUITING · NA
-
Listening Effort in Cochlear Implant Users
RECRUITING · NA
-
Characterizing Variability in Hearing Aid Outcomes in Among Older Adults With Alzheimer's Dementia
RECRUITING · NA
-
Reading Outcomes in Children With Vestibular Loss
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02090140 · 17 participants · NA
Microfracture Versus Adipose Derived Stem Cells for the Treatment of Articular Cartilage Defects
- NCT03317860 · 17 participants · NA
Improving Measurement and Treatment of Post-stroke Neglect
- NCT04356469 · 17 participants · Phase 2
TCR Alpha Beta T-cell Depleted Haploidentical HCT in the Treatment of Non-Malignant Hematological Disorders in Children
- NCT04414046 · 17 participants · Phase 2
TCR Alpha Beta T-cell Depleted Haploidentical HCT in the Treatment of Primary Immunodeficiency and Inherited Metabolic Disorders in Children
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI